Clinical and molecular prognostic factors in operable laryngeal cancer

European Archives of Oto-Rhino-Laryngology

Volumn 262, Issue 11, 2005, Pages 890-898

  Vlachtsis, Konstantinos ^a   Nikolaou, Angelos ^a   Markou, Konstantinos ^a   Fountzilas, George ^b   Daniilidis, Ioannis ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

bcl 2; EBV; EGFR; HPV; Laryngeal cancer; p 53; Prognostic factors; VEGF

Indexed keywords

BIOLOGICAL MARKER; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; GENOMIC DNA; PROTEIN BCL 2; PROTEIN P53; RNA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; DEMOGRAPHY; DNA EXTRACTION; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; GLOTTIS; HISTOPATHOLOGY; HUMAN; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA ISOLATION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TUMOR LOCALIZATION; TUMOR RECURRENCE; VIRUS DETECTION; WART VIRUS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DNA, COMPLEMENTARY; DNA, NEOPLASM; FEMALE; GENES, P53; HERPESVIRUS 4, HUMAN; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 28844485098     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-005-0916-3     Document Type: Article

References (55)

1. Aaltonen L M, Rihkanen H, Vaheri A (2002) Human papillomavirus in larynx. Laryngoscope 112:700-707
2. Almadori G, Cadoni G, Galli J, Ferrandina G, Scambia G, Exarchakos G, Paludetti G, Ottaviani F (1999) Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor. Int J Cancer 84:188-191
3. Assimakopoulos D, Kolettas E, Zagorianakou N, Evangelou A, Skevas A, Agnantis NJ (2000) Prognostic significance of p53 in the cancer of the larynx. Anticancer Res 20:3555-3564
4. Barra S, Barzan L, Maione A, Cadelano A, Pin M, Franceschi S, Comoretto R (1994) Blood transfusion and other prognostic variables in the survival of patients with cancer of the head and neck. Laryngoscope 104:95-98
5. Baselga J, Hammond LA (2002) HER-targeted tyrosine-kinase inhibitors. Oncology 63 [Suppl 1]:6-16
6. Boffeta P, Merletti F, Faggiano F, Migliaretti G, Ferro G, Zanetti R, Terracini B (1997) Prognostic factors and survival of laryngeal cancer patients from Turin, Italy. A population-based study. Am J Epidemiol 145:1100-1105
7. Brasilino de Carvalho M (1998) Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head Neck 20:16-21
8. Bryne M, Jenssen N, Boysen M (1995) Histological grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virchows Arch 427:277-281
9. Capone R, Pai S, Koch W, et al (2000) Detection and quantification of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res 6:4171-4175
10. Carrillo JF, Frias-Mendivil M, Lopez-Graniel C, Beitia AI, Ochoa-Carrillo FJ (1999) The impact of preoperative tracheotomy on T3 transglottic carcinomas of the larynx. Eur Arch Otorhinolaryngol 256:78-82
11. Codd JD, Salisbury JR, Packham G, Nicholson LJ (1999) A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma. J Pathol 187:549-555
12. Danic D, Maruic M, Uzarevic B, Milicic D (2000) Prognostic factors in squamous cell carcinoma of the larynx. ORL J Otorhinolaryngol Relat Spec 62:143-148
13. Eiband JD, Elias EG, Suter CM, Gray WC, Didolkar MS (1989) Prognostic factors in squamous cell carcinoma of the larynx. Am J Surg 158:314-317
14. Forastiere A, Koch W, Trotti A, Sidransky D (2001) Head and neck cancer. N Engl J Med 345:1890-1900
15. Ford AC, Grandis JR (2003) Targeting epidermal growth factor receptor in head and neck cancer. Head Neck 25:67-73
16. Geisler S, Olsham A, Weissler M, et al (2002) p16 and p53 expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res 8:3445-3453
17. Hardisson D (2003) Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 260:502-508
18. Hirvikoski P, Kumpulainen E, Virtaniemi J, Pirinen R, Salmi L, Halonen P, Johansson R, Kosma VM (1999) Enhanced apoptosis correlates with poor survival in patients with laryngeal cancer but not with cell proliferation, bcl-2 or p53 expression. Eur J Cancer 35:231-237
19. Hotz MA, Bosq J, Zbaeren P, Reed J, Schwab G, Krajewski S, Brousset P, Borner MM (1999) Spontaneous apoptosis and the expression of p53 and bcl-2 family proteins in locally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 125:417-422
20. Jackel MC, Dorudian MA, Marx D, Brinck U, Schauer A, Steiner W (1999) Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression. Cancer 85:591-599
21. Jeannon JP, Soames J, Lunec J, Awwad S, Ashton V, Wilson JA (2000) Expression of cyclin-dependent kinase inhibitor p21(WAF1) and p53 tumour suppressor gene in laryngeal carcer. Clin Otolaryngol 25:23-27
22. Jin YT, Kayser S, Kemp BL, Ordonez NG, Tucker SL, Clayman GL, Goepfert H, Luna MA, Batsakis JG, El-Naggar AK (1998) The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer 82:2159-2165
23. Kowalski LP, Franco EL, de Andrade Sobrinho J, Oliveira BV, Pontes PL (1991) Prognostic factors in laryngeal cancer patients submitted to surgical treatment. J Surg Oncol 48:87-95
24. Lassaletta L, Garcia-Pallares M, Morera E, Bernaldez R, Gavilan J (2001) T3 glottic cancer: oncologic results and prognostic factors. Otolaryngol Head Neck Surg 124:556-560
25. Lee DW, Sung MW, Park SW, Seong WJ, Roh JL, Park B, Heo DS, Kim KH (2002) Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Anticancer Res 22:2089-2096
26. Lin DT, Subbaramaiah K, Shah JP, Dannenberg AJ, Boyle JO (2002) Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck 24:792-799
27. Markou K, Vlachtsis K, Nikolaou A, Petridis D, Kouloulas A, Daniilidis I (2004) Incidence and predisposing factors of pharyngocutaneous fistula formation after total laryngectomy. Is there a relationship with tumor recurrence? Eur Arch Otorhinolaryngol 261:61-67
28. Maurizi M, Almadori G, Ferrandina G, Distefano M, Romanini ME, Cadoni G, Benedetti-Panici P, Paludetti G, Scambia G, Mancuso S (1996) Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 74:1253-1257
29. Mielcarek-Kuchta D, Olofsson J, Golusinski W (2003) p53, Ki67 and cyclin D1 as prognostic factors of lymph node metastases in laryngeal carcinoma. Eur Arch Otorhinolaryngol 260:549-554
30. Mineta H, Miura K, Ogino T, Takebayashi S, Misawa K, Ueda Y, Suzuki I, Dictor M, Borg A, Wennerberg J (2000) Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer 83:775-781
31. Modjtahedi H, Moscatello DK, Box G, Green M, Shotton C, Lamb DJ, Reynolds LJ, Wong AJ, Dean C, Thomas H, Eccles S (2003) Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy. Int J Cancer 105:273-280
32. Morales-Angulo C, Val-Bernal F, Buelta L, Fernandez F, Garcia-Castrillo L, Rama J (1998) Prognostic factors in supraglottic laryngeal carcinoma. Otolaryngol Head Neck Surg 119:548-553
33. Nakashima T, Wang XF, Masuda M, Inokuchi A, Komiyama S (1999) Overexpression of p53 nuclear protein in premelignant and malignant laryngeal lesions. Eur Arch Otorhinolaryngol 256 [Suppl 1]:S56-59
34. Narayana A, Vaughan AT, Gunaratne S, Kathuria S, Walter SA, Reddy SP (1998) Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer 82:286-291
35. Nathan CA, Sanders K, Abreo FW, Nassar R, Glass J (2000) Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications. Cancer Res 60:3599-3604
36. Neuchrist C, Quint C, Pammer A, Burian M (1999) Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study. Acta Otolaryngol 119:732-738
37. Nicolai P, Redaelli de Zinis LO, Tomenzoli D, Barezzani MG, Bertoni F, Bignardi M, Antonelli AR (1997) Prognostic determinants in supraglottic carcinoma: univariate and Cox regression analysis. Head Neck 19:323-334
38. O-charoenrat P, Rhys-Evans P, Eccles S (2001) Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma corelates with lymph node metastasis. Cancer 92:556-568
39. Pulkkinen JO, Klemi P, Martikainen P, Grenman R (1999) Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma. Anticancer Res 19:703-707
40. Ranson M (2002) ZD1839 (Iressa): for more than just non-small cell lung cancer. Oncologist 7 [Suppl 4]:16-24
41. Riedel F, Gotte K, Schwalb J, Bergler W, Hormann K (2000) Expression of 92-kDa type IV collagenase correlates with angiogenesis markers and poor survival in head and neck squamous cell carcinoma. Int J Oncol 17:1099-1105
42. Rowley H, Roland NJ, Helliwell TR, Caslin A, Kinsella AR, Jones AS (1998) p53 protein expression in tumours from the head and neck subsites, larynx and hypopharynx, and differences in relationship to survival. Clin Otolaryngol 23:57-62
43. Rubin J, Johnson JT, Myers EN (1990) Stomal recurrence after laryngectomy: interrelated risk factor study. Otolaryngol Head Neck Surg 103:805-812
44. Sittel C, Ecke HE, Damm M, von Pritzbuer E, Kvasnicka HM (2000) Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma. Laryngoscope 110:1012-1017
45. Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA (2001) Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of larynx and hypopharynx. Laryngoscope 111:1079-1087
46. Stankiewicz C (1994) Prognostic significance of lymph node reactivity in patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol 251:418-422
47. Takes RP, Baatenburg de Jong RJ, Scuuring E, Hermans J, Vis AA, Litvinov SV, van Krieken JH (2002) Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 123:412-419
48. Weber A, Tannapfel A (2002) Prognosefactoren bei Kopf-Halskarzinomen. HNO 50:35-42
49. Welkoborsky HJ, Hinni M, Dienes HP, Mann WJ (1995) Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann Otol Rhinol Laryngol 104:503-510
50. Yang HJ, Cho YJ, Kim HS, Chang MS, Sung MW, Kim WH (2001) Association of p53 and BCL-2 expression with Epstein-Barr virus infection in the cancers of head and neck. Head Neck 23:629-636
51. Yilmaz T, Hosal AS, Gedikoglu G, Onerci M, Gursel B (1998) Prognostic significance of vascular and perineural invation in cancer of the larynx. Am J Otolaryngol 19:83-88
52. Yilmaz T, Hosal S, Gedikoglou G, Turan E, Ayas K (1998) Prognostic significance of depth of invasion in cancer of the larynx. Laryngoscope 108:764-768
53. Yuen AP, Wei WI, Ho WK, Hui Y (1996) Risk factors of tracheostomal recurrence after laryngectomy for laryngeal carcinoma. Am J Surg 172:263-266
54. Yuen PW, Lam KY, Choy JT, Ho WT, Wei WI (2000) Clinicopathological significance of p53 and p21 expression in the surgical treatment of laryngeal carcinoma. Anticancer Res 20:4863-4866
55. Vielba R, Bilbao J, Ispizua A, et al (2003) p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 113:167-172